{
    "bib_entries": {
        "bib0160": {
            "authors": [
                {
                    "first": "Lelia",
                    "initial": "L.",
                    "last": "Duley"
                }
            ],
            "doi": "10.1053/j.semperi.2009.02.010",
            "firstpage": "130",
            "issn": "01460005",
            "lastpage": "137",
            "pmid": "19464502",
            "pub_year": 2009,
            "title": "The Global Impact of Pre-eclampsia and Eclampsia",
            "volume": "33"
        },
        "bib0165": {
            "authors": [
                {
                    "first": "Eric A.P.",
                    "initial": "E.A.P.",
                    "last": "Steegers"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Von Dadelszen"
                },
                {
                    "first": "Johannes J.",
                    "initial": "J.J.",
                    "last": "Duvekot"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Pijnenborg"
                }
            ],
            "doi": "10.1016/S0140-6736(10)60279-6",
            "firstpage": "631",
            "issn": "01406736",
            "lastpage": "644",
            "pmid": "20598363",
            "pub_year": 2010,
            "title": "Pre-eclampsia",
            "volume": "376"
        },
        "bib0170": {
            "authors": [
                {
                    "first": "Babbette D.",
                    "initial": "B.D.",
                    "last": "LaMarca"
                },
                {
                    "first": "Jeffery",
                    "initial": "J.",
                    "last": "Gilbert"
                },
                {
                    "first": "Joey P.",
                    "initial": "J.P.",
                    "last": "Granger"
                }
            ],
            "doi": "10.1161/HYPERTENSIONAHA.107.108837",
            "firstpage": "982",
            "issn": "0194911X",
            "lastpage": "988",
            "pmid": "18259004",
            "pub_year": 2008,
            "title": "Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia",
            "volume": "51"
        },
        "bib0175": {
            "authors": [
                {
                    "first": "Jeffrey S.",
                    "initial": "J.S.",
                    "last": "Gilbert"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Ryan"
                },
                {
                    "first": "Babbette B.",
                    "initial": "B.B.",
                    "last": "Lamarca"
                },
                {
                    "first": "Mona",
                    "initial": "M.",
                    "last": "Sedeek"
                },
                {
                    "first": "Sydney R.",
                    "initial": "S.R.",
                    "last": "Murphy"
                },
                {
                    "first": "Joey P.",
                    "initial": "J.P.",
                    "last": "Granger"
                }
            ],
            "doi": "10.1152/ajpheart.01113.2007",
            "firstpage": "H541",
            "issn": "03636135",
            "lastpage": "H550",
            "pmid": "18055511",
            "pub_year": 2008,
            "title": "Pathophysiology of hypertension during preeclampsia: Linking placental ischemia with endothelial dysfunction",
            "volume": "294"
        },
        "bib0180": {
            "authors": [
                {
                    "first": "Katrin S.",
                    "initial": "K.S.",
                    "last": "Kohl"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Gidudu"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Bonhoeffer"
                },
                {
                    "first": "M. Miles",
                    "initial": "M.M.",
                    "last": "Braun"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Buettcher"
                },
                {
                    "first": "Robert T.",
                    "initial": "R.T.",
                    "last": "Chen"
                },
                {
                    "first": "Bakary",
                    "initial": "B.",
                    "last": "Drammeh"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Duclos"
                },
                {
                    "first": "Harald",
                    "initial": "H.",
                    "last": "Heijbel"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Heininger"
                },
                {
                    "first": "Erik",
                    "initial": "E.",
                    "last": "Hummelman"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Jefferson"
                },
                {
                    "first": "Brigitte",
                    "initial": "B.",
                    "last": "Keller-Stanislawski"
                },
                {
                    "first": "Elisabeth",
                    "initial": "E.",
                    "last": "Loupi"
                },
                {
                    "first": "S. Michael",
                    "initial": "S.M.",
                    "last": "Marcy"
                }
            ],
            "doi": "10.1016/j.vaccine.2007.02.063",
            "firstpage": "5671",
            "issn": "0264410X",
            "lastpage": "5674",
            "pmid": "17400339",
            "pub_year": 2007,
            "title": "The development of standardized case definitions and guidelines for adverse events following immunization",
            "volume": "25"
        },
        "bib0185": {
            "authors": [
                {
                    "first": "Alies",
                    "initial": "A.",
                    "last": "Coenders"
                },
                {
                    "first": "Nienke K.",
                    "initial": "N.K.",
                    "last": "Koopmans"
                },
                {
                    "first": "Kim",
                    "initial": "K.",
                    "last": "Broekhuijsen"
                },
                {
                    "first": "Henk",
                    "initial": "H.",
                    "last": "Groen"
                },
                {
                    "first": "Janna M.A.",
                    "initial": "J.M.A.",
                    "last": "Karstenberg-Kramer"
                },
                {
                    "first": "Kim",
                    "initial": "K.",
                    "last": "Van Goor"
                },
                {
                    "first": "Mariette",
                    "initial": "M.",
                    "last": "Groenewout"
                },
                {
                    "first": "Aren J.",
                    "initial": "A.J.",
                    "last": "Van Loon"
                },
                {
                    "first": "Marijke M.",
                    "initial": "M.M.",
                    "last": "Faas"
                },
                {
                    "first": "Maria G.",
                    "initial": "M.G.",
                    "last": "Van Pampus"
                }
            ],
            "doi": "10.1016/j.ejogrb.2015.01.011",
            "firstpage": "14",
            "issn": "03012115",
            "lastpage": "19",
            "pmid": "25681994",
            "pub_year": 2015,
            "title": "Adjuvanted vaccines in pregnancy: No evidence for effect of the adjuvanted H1N1/09 vaccination on occurrence of preeclampsia or intra-uterine growth restriction",
            "volume": "187"
        },
        "bib0190": {
            "authors": [
                {
                    "first": "Michael R.",
                    "initial": "M.R.",
                    "last": "Millar"
                },
                {
                    "first": "Marta G.onzalez",
                    "initial": "M.G.o.",
                    "last": "Sanz"
                }
            ],
            "doi": "10.1136/ebmed-2014-110149",
            "firstpage": "73",
            "issn": "14736810",
            "pmid": "25686618",
            "pub_year": 2015,
            "title": "The administration of pertussis vaccine to pregnant women was associated with a small increased risk of chorioamnionitis, but not an increased risk of hypertensive disorders or preterm birth",
            "volume": "20"
        },
        "bib0195": {
            "authors": [
                {
                    "first": "Elyse Olshen",
                    "initial": "E.O.",
                    "last": "Kharbanda"
                },
                {
                    "first": "Gabriela",
                    "initial": "G.",
                    "last": "Vazquez-Benitez"
                },
                {
                    "first": "Heather",
                    "initial": "H.",
                    "last": "Lipkind"
                },
                {
                    "first": "Allison",
                    "initial": "A.",
                    "last": "Naleway"
                },
                {
                    "first": "Grace",
                    "initial": "G.",
                    "last": "Lee"
                },
                {
                    "first": "James D.",
                    "initial": "J.D.",
                    "last": "Nordin"
                }
            ],
            "doi": "10.1097/AOG.0b013e3182a1118a",
            "firstpage": "659",
            "issn": "00297844",
            "lastpage": "667",
            "pmid": "23921876",
            "pub_year": 2013,
            "title": "Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events",
            "volume": "122"
        },
        "bib0200": {
            "authors": [
                {
                    "first": "Ava Marie S.",
                    "initial": "A.M.S.",
                    "last": "Conlin"
                },
                {
                    "first": "Anna T.",
                    "initial": "A.T.",
                    "last": "Bukowinski"
                },
                {
                    "first": "Carter J.",
                    "initial": "C.J.",
                    "last": "Sevick"
                },
                {
                    "first": "Connie",
                    "initial": "C.",
                    "last": "DeScisciolo"
                },
                {
                    "first": "Nancy F.",
                    "initial": "N.F.",
                    "last": "Crum-Cianflone"
                }
            ],
            "doi": "10.1097/AOG.0b013e318280d64e",
            "firstpage": "511",
            "issn": "00297844",
            "lastpage": "518",
            "pmid": "23635612",
            "pub_year": 2013,
            "title": "Safety of the pandemic H1N1 Influenza Vaccine Among Pregnant U.S. Military Women and Their Newborns",
            "volume": "121"
        },
        "bib0205": {
            "authors": [
                {
                    "first": null,
                    "initial": null,
                    "last": "American College of Obstetricians"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": "Task Force on Hypertension in Pregnancy"
                }
            ],
            "firstpage": "1122",
            "issn": "1873233X",
            "lastpage": "1131",
            "pmid": "24150027",
            "pub_year": 2013,
            "title": "Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy.",
            "volume": "122"
        },
        "bib0210": {
            "authors": [
                {
                    "first": "Sarka",
                    "initial": "S.",
                    "last": "Lisonkova"
                },
                {
                    "first": "K. S.",
                    "initial": "K.S.",
                    "last": "Joseph"
                }
            ],
            "doi": "10.1016/j.ajog.2013.08.019",
            "firstpage": "544",
            "issn": "00029378",
            "lastpage": "544.e12",
            "pmid": "23973398",
            "pub_year": 2013,
            "title": "Incidence of preeclampsia: Risk factors and outcomes associated with early-versus late-onset disease",
            "volume": "209"
        },
        "bib0215": {
            "authors": [
                {
                    "first": "Jim",
                    "initial": "J.",
                    "last": "Sikorski"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Wilson"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Clement"
                }
            ],
            "doi": "10.1111/j.1471-0528.1998.tb10139.x",
            "firstpage": "473",
            "issn": "14700328",
            "pmid": "9609281",
            "pub_year": 1998,
            "title": "The changing pattern of eclampsia over a 60-year period",
            "volume": "105"
        },
        "bib0220": {
            "authors": [
                {
                    "first": "Yifru",
                    "initial": "Y.",
                    "last": "Berhan"
                },
                {
                    "first": "Asres",
                    "initial": "A.",
                    "last": "Berhan"
                }
            ],
            "doi": "10.1111/jog.12697",
            "firstpage": "831",
            "issn": "13418076",
            "lastpage": "842",
            "pmid": "25833188",
            "pub_year": 2015,
            "title": "Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia",
            "volume": "41"
        },
        "bib0225": null,
        "bib0230": {
            "authors": [
                {
                    "first": "Sandra A.",
                    "initial": "S.A.",
                    "last": "Lowe"
                },
                {
                    "first": "Mark A.",
                    "initial": "M.A.",
                    "last": "Brown"
                },
                {
                    "first": "Gustaaf A.",
                    "initial": "G.A.",
                    "last": "Dekker"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Gatt"
                },
                {
                    "first": "Claire K.",
                    "initial": "C.K.",
                    "last": "Mclintock"
                },
                {
                    "first": "Lawrence P.",
                    "initial": "L.P.",
                    "last": "Mcmahon"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Mangos"
                },
                {
                    "first": "M. Peter",
                    "initial": "M.P.",
                    "last": "Moore"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Muller"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Paech"
                },
                {
                    "first": "Barry",
                    "initial": "B.",
                    "last": "Walters"
                }
            ],
            "doi": "10.1111/j.1479-828X.2009.01003.x",
            "firstpage": "242",
            "issn": "00048666",
            "lastpage": "246",
            "pmid": "19566552",
            "pub_year": 2009,
            "title": "Guidelines for the management of hypertensive disorders of pregnancy 2008",
            "volume": "49"
        },
        "bib0235": {
            "authors": [
                {
                    "first": "Laura A.",
                    "initial": "L.A.",
                    "last": "Magee"
                },
                {
                    "first": "Anouk",
                    "initial": "A.",
                    "last": "Pels"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Helewa"
                },
                {
                    "first": "Evelyne",
                    "initial": "E.",
                    "last": "Rey"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "von Dadelszen"
                }
            ],
            "doi": "10.1016/S1701-2163(15)30533-8",
            "firstpage": "575",
            "issn": "17012163",
            "lastpage": "576",
            "pmid": "25184972",
            "pub_year": 2014,
            "title": "In Response",
            "volume": "36"
        },
        "bib0240": {
            "authors": [
                {
                    "first": "M. A.",
                    "initial": "M.A.",
                    "last": "Brown"
                },
                {
                    "first": "M. L.",
                    "initial": "M.L.",
                    "last": "Buddie"
                }
            ],
            "doi": "10.1111/j.1479-828X.1995.tb02143.x",
            "firstpage": "366",
            "issn": "00048666",
            "lastpage": "369",
            "pmid": "8717555",
            "pub_year": 1995,
            "title": "Inadequacy of Dipstick Proteinuria in Hypertensive Pregnancy",
            "volume": "35"
        },
        "bib0245": {
            "authors": [
                {
                    "first": "Patrick J.",
                    "initial": "P.J.",
                    "last": "Saudan"
                },
                {
                    "first": "Mark A.",
                    "initial": "M.A.",
                    "last": "Brown"
                },
                {
                    "first": "Tanya",
                    "initial": "T.",
                    "last": "Farrell"
                },
                {
                    "first": "Loretta",
                    "initial": "L.",
                    "last": "Shaw"
                }
            ],
            "doi": "10.1111/j.1471-0528.1997.tb10940.x",
            "firstpage": "1159",
            "issn": "14700328",
            "lastpage": "1164",
            "pmid": "9332994",
            "pub_year": 1997,
            "title": "Improved methods of assessing proteinuria in hypertensive pregnancy",
            "volume": "104"
        },
        "bib0250": {
            "authors": [
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Von Dadelszen"
                },
                {
                    "first": "Beth",
                    "initial": "B.",
                    "last": "Payne"
                },
                {
                    "first": "Jing",
                    "initial": "J.",
                    "last": "Li"
                },
                {
                    "first": "J. Mark",
                    "initial": "J.M.",
                    "last": "Ansermino"
                },
                {
                    "first": "Fiona Broughton",
                    "initial": "F.B.",
                    "last": "Pipkin"
                },
                {
                    "first": "Anne Marie",
                    "initial": "A.M.",
                    "last": "C\u00f4t\u00e9"
                },
                {
                    "first": "M. Joanne",
                    "initial": "M.J.",
                    "last": "Douglas"
                },
                {
                    "first": "Andr\u00e9e",
                    "initial": "A.",
                    "last": "Gruslin"
                },
                {
                    "first": "Jennifer A.",
                    "initial": "J.A.",
                    "last": "Hutcheon"
                },
                {
                    "first": "K. S.",
                    "initial": "K.S.",
                    "last": "Joseph"
                },
                {
                    "first": "Phillipa M.",
                    "initial": "P.M.",
                    "last": "Kyle"
                },
                {
                    "first": "Tang",
                    "initial": "T.",
                    "last": "Lee"
                },
                {
                    "first": "Pamela",
                    "initial": "P.",
                    "last": "Loughna"
                },
                {
                    "first": "Jennifer M.",
                    "initial": "J.M.",
                    "last": "Menzies"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Merialdi"
                },
                {
                    "first": "Alexandra L.",
                    "initial": "A.L.",
                    "last": "Millman"
                },
                {
                    "first": "M. Peter",
                    "initial": "M.P.",
                    "last": "Moore"
                },
                {
                    "first": "Jean Marie",
                    "initial": "J.M.",
                    "last": "Moutquin"
                },
                {
                    "first": "Annie B.",
                    "initial": "A.B.",
                    "last": "Ouellet"
                },
                {
                    "first": "Graeme N.",
                    "initial": "G.N.",
                    "last": "Smith"
                },
                {
                    "first": "James J.",
                    "initial": "J.J.",
                    "last": "Walker"
                },
                {
                    "first": "Keith R.",
                    "initial": "K.R.",
                    "last": "Walley"
                },
                {
                    "first": "Barry N.",
                    "initial": "B.N.",
                    "last": "Walters"
                },
                {
                    "first": "Mariana",
                    "initial": "M.",
                    "last": "Widmer"
                },
                {
                    "first": "Shoo K.",
                    "initial": "S.K.",
                    "last": "Lee"
                },
                {
                    "first": "James A.",
                    "initial": "J.A.",
                    "last": "Russell"
                },
                {
                    "first": "Laura A.",
                    "initial": "L.A.",
                    "last": "Magee"
                }
            ],
            "doi": "10.1016/S0140-6736(10)61351-7",
            "firstpage": "219",
            "issn": "01406736",
            "lastpage": "227",
            "pmid": "21185591",
            "pub_year": 2011,
            "title": "Prediction of adverse maternal outcomes in pre-eclampsia: Development and validation of the fullPIERS model",
            "volume": "377"
        },
        "bib0255": {
            "authors": [
                {
                    "first": "Nina M.",
                    "initial": "N.M.",
                    "last": "Roos"
                },
                {
                    "first": "Marjon J.",
                    "initial": "M.J.",
                    "last": "Wiegman"
                },
                {
                    "first": "Nomdo M.",
                    "initial": "N.M.",
                    "last": "Jansonius"
                },
                {
                    "first": "Gerda G.",
                    "initial": "G.G.",
                    "last": "Zeeman"
                }
            ],
            "doi": "10.1097/OGX.0b013e318250a457",
            "firstpage": "242",
            "issn": "00297828",
            "lastpage": "250",
            "pmid": "22495060",
            "pub_year": 2012,
            "title": "Visual disturbances in (pre)eclampsia",
            "volume": "67"
        },
        "bib0260": {
            "authors": [
                {
                    "first": "Shamil D.",
                    "initial": "S.D.",
                    "last": "Cooray"
                },
                {
                    "first": "Sally M.",
                    "initial": "S.M.",
                    "last": "Edmonds"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Tong"
                },
                {
                    "first": "Sumudu P.",
                    "initial": "S.P.",
                    "last": "Samarasekera"
                },
                {
                    "first": "Clare L.",
                    "initial": "C.L.",
                    "last": "Whitehead"
                }
            ],
            "doi": "10.1097/AOG.0b013e3182324570",
            "firstpage": "995",
            "issn": "00297844",
            "lastpage": "999",
            "pmid": "22015866",
            "pub_year": 2011,
            "title": "Characterization of symptoms immediately preceding eclampsia",
            "volume": "118"
        },
        "bib0265": {
            "authors": [
                {
                    "first": "Baha M.",
                    "initial": "B.M.",
                    "last": "Sibai"
                }
            ],
            "doi": "10.1097/01.AOG.0000126245.35811.2a",
            "firstpage": "981",
            "issn": "00297844",
            "lastpage": "991",
            "pmid": "15121574",
            "pub_year": 2004,
            "title": "Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count",
            "volume": "103"
        },
        "bib0270": {
            "authors": [
                {
                    "first": "Jr",
                    "initial": "J.",
                    "last": "Martin"
                },
                {
                    "first": "B. K.",
                    "initial": "B.K.",
                    "last": "Rinehart"
                },
                {
                    "first": "W. L.",
                    "initial": "W.L.",
                    "last": "May"
                },
                {
                    "first": "E. F.",
                    "initial": "E.F.",
                    "last": "Magann"
                },
                {
                    "first": "D. A.",
                    "initial": "D.A.",
                    "last": "Terrone"
                },
                {
                    "first": "P. G.",
                    "initial": "P.G.",
                    "last": "Blake"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Lowery"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Entman"
                }
            ],
            "doi": "10.1016/S0002-9378(99)70022-0",
            "firstpage": "1373",
            "issn": "00029378",
            "lastpage": "1384",
            "pmid": "10368474",
            "pub_year": 1999,
            "title": "The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification",
            "volume": "180"
        },
        "bib0275": {
            "authors": [
                {
                    "first": "Baha M.",
                    "initial": "B.M.",
                    "last": "Sibai"
                }
            ],
            "doi": "10.1016/S0029-7844(02)02128-2",
            "firstpage": "369",
            "issn": "00297844",
            "lastpage": "377",
            "pmid": "12151166",
            "pub_year": 2002,
            "title": "Chronic hypertension in pregnancy",
            "volume": "100"
        },
        "bib0280": null,
        "bib0285": {
            "authors": [
                {
                    "first": "Baha M.",
                    "initial": "B.M.",
                    "last": "Sibai"
                }
            ],
            "doi": "10.1016/j.ajog.2011.09.002",
            "firstpage": "470",
            "issn": "00029378",
            "lastpage": "475",
            "pmid": "21963308",
            "pub_year": 2012,
            "title": "Etiology and management of postpartum hypertension-preeclampsia",
            "volume": "206"
        },
        "bib0290": null,
        "bib0295": null,
        "bib0300": {
            "authors": [
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Moher"
                },
                {
                    "first": "Kenneth F.",
                    "initial": "K.F.",
                    "last": "Schulz"
                },
                {
                    "first": "Douglas",
                    "initial": "D.",
                    "last": "Altman"
                }
            ],
            "doi": "10.1001/jama.285.15.1987",
            "firstpage": "1987",
            "issn": "00987484",
            "lastpage": "1991",
            "pmid": "11308435",
            "pub_year": 2001,
            "title": "The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials",
            "volume": "285"
        },
        "bib0305": {
            "authors": [
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Moher"
                },
                {
                    "first": "Deborah J.",
                    "initial": "D.J.",
                    "last": "Cook"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Eastwood"
                },
                {
                    "first": "Ingram",
                    "initial": "I.",
                    "last": "Olkin"
                },
                {
                    "first": "Drummond",
                    "initial": "D.",
                    "last": "Rennie"
                },
                {
                    "first": "Donna F.",
                    "initial": "D.F.",
                    "last": "Stroup"
                }
            ],
            "doi": "10.1016/S0140-6736(99)04149-5",
            "firstpage": "1896",
            "issn": "01406736",
            "lastpage": "1900",
            "pmid": "10584742",
            "pub_year": 1999,
            "title": "Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement",
            "volume": "354"
        },
        "bib0310": {
            "authors": [
                {
                    "first": "Donna F.",
                    "initial": "D.F.",
                    "last": "Stroup"
                },
                {
                    "first": "Jesse A.",
                    "initial": "J.A.",
                    "last": "Berlin"
                },
                {
                    "first": "Sally C.",
                    "initial": "S.C.",
                    "last": "Morton"
                },
                {
                    "first": "Ingram",
                    "initial": "I.",
                    "last": "Olkin"
                },
                {
                    "first": "G. David",
                    "initial": "G.D.",
                    "last": "Williamson"
                },
                {
                    "first": "Drummond",
                    "initial": "D.",
                    "last": "Rennie"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Moher"
                },
                {
                    "first": "Betsy J.",
                    "initial": "B.J.",
                    "last": "Becker"
                },
                {
                    "first": "Theresa Ann",
                    "initial": "T.A.",
                    "last": "Sipe"
                },
                {
                    "first": "Stephen B.",
                    "initial": "S.B.",
                    "last": "Thacker"
                }
            ],
            "doi": "10.1001/jama.283.15.2008",
            "firstpage": "2008",
            "issn": "00987484",
            "lastpage": "2012",
            "pmid": "10789670",
            "pub_year": 2000,
            "title": "Meta-analysis of observational studies in epidemiology: A proposal for reporting",
            "volume": "283"
        }
    },
    "body_text": [
        {
            "endOffset": 17844,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Other organ systems will manifest this dysfunction in fashions specific to their physiology.",
            "startOffset": 17752,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 10345,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0015",
            "sentence": "The composition of the working and reference group as well as results of the web-based survey completed by the reference group with subsequent discussions in the working group can be viewed at: http://www.brightoncollaboration.org/internet/en/index/working_groups.html.",
            "startOffset": 10076,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 21729,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "http://www.brightoncollaboration.org.",
            "startOffset": 21692,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 21892,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "secId": "sec0060",
            "sentence": "HELLP syndrome is considered to be a subtype of severe preeclampsia.",
            "startOffset": 21824,
            "title": "HELLP (Hemolysis, Elevated Liver Enzymes, Low Platelets) syndrome"
        },
        {
            "endOffset": 7627,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "It is important to provide definitions that can be utilized widely.",
            "startOffset": 7560,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 25880,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0080",
            "sentence": "Ensuring accurate diagnosis is of great importance, as treatment can vary widely based on the etiology of the patient's symptoms.",
            "startOffset": 25751,
            "title": "Differential diagnoses"
        },
        {
            "endOffset": 17623,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "refoffsets": {
                "bib0165": {
                    "endOffset": 17622,
                    "startOffset": 17610
                },
                "bib0205": {
                    "endOffset": 17622,
                    "startOffset": 17610
                },
                "bib0225": {
                    "endOffset": 17622,
                    "startOffset": 17610
                },
                "bib0230": {
                    "endOffset": 17622,
                    "startOffset": 17610
                },
                "bib0235": {
                    "endOffset": 17622,
                    "startOffset": 17610
                }
            },
            "secId": "sec0050",
            "sentence": "Preeclampsia has conventionally been defined as the development of gestational hypertension and proteinuria after 20 weeks gestation [2,10,14\u201316].",
            "startOffset": 17477,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 20910,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Pulmonary edema (confirmed on clinical exam or imaging)",
            "startOffset": 20855,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 19428,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "The diagnosis of severe preeclampsia requires new onset hypertension (as described above) and one of the following criteria enumerated below.",
            "startOffset": 19287,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 44434,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "Data should be presented with numerator and denominator (n/N) (and not only in percentages), if available.",
            "startOffset": 44328,
            "title": "Data presentation"
        },
        {
            "endOffset": 22028,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "refoffsets": {
                "bib0265": {
                    "endOffset": 22027,
                    "startOffset": 22020
                },
                "bib0270": {
                    "endOffset": 22027,
                    "startOffset": 22020
                }
            },
            "secId": "sec0060",
            "sentence": "The diagnosis is based on laboratory evaluation in which all criteria (hemolysis, liver dysfunction, thrombocytopenia) are met [22,23].",
            "startOffset": 21893,
            "title": "HELLP (Hemolysis, Elevated Liver Enzymes, Low Platelets) syndrome"
        },
        {
            "endOffset": 9412,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "There are observational studies as well as case reports of hypertensive disease developing in women after vaccine administration but no causal link has been described.",
            "startOffset": 9245,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 34133,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                }
            ],
            "secId": "sec0130",
            "sentence": "Date and time of immunization(s).",
            "startOffset": 34100,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 15473,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "The use of \u201c20 weeks gestation\u201d as a diagnostic criterion is somewhat arbitrary, as there is no specific physiologic change known that occurs at this gestational age that permits the development of preeclampsia.",
            "startOffset": 15262,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 7237,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "This is a missed opportunity, as data comparability across trials or surveillance systems would facilitate data interpretation and promote the scientific understanding of the event.",
            "startOffset": 7056,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 25182,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0075",
            "sentence": "In order to avoid selecting against such cases, the Brighton Collaboration case definition avoids setting arbitrary time frames, though the immunization should precede the hypertensive disorder.",
            "startOffset": 24988,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 42346,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Analysis may also include other characteristics like qualitative patterns of criteria defining the event.",
            "startOffset": 42241,
            "title": "Data analysis"
        },
        {
            "endOffset": 33448,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                },
                {
                    "id": "sec0115",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "sec0125",
            "sentence": "Past medical history, including hospitalisations, underlying diseases/disorders, pre-immunization signs and symptoms including identification of indicators for, or the absence of, a history of allergy to vaccines, vaccine components or medications; food allergy; allergic rhinitis; eczema; asthma.",
            "startOffset": 33151,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 45445,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "The method, frequency and duration of monitoring for the hypertensive disorders of pregnancy;",
            "startOffset": 45352,
            "title": "Data presentation"
        },
        {
            "endOffset": 9550,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "Furthermore, the case definitions for the observational studies are not well defined, with several studies relying solely on ICD-9 codes.",
            "startOffset": 9413,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 46643,
            "parents": [],
            "secId": "sec0155",
            "sentence": "The findings, opinions and assertions contained in this consensus document are those of the individual scientific professional members of the working group.",
            "startOffset": 46487,
            "title": "Disclaimer"
        },
        {
            "endOffset": 15854,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "The WHO released a document in 2003 detailing the proper protocols and techniques that should be utilized when measuring blood pressure.",
            "startOffset": 15718,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 34322,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                }
            ],
            "secId": "sec0130",
            "sentence": "Description of vaccine(s) (name of vaccine, manufacturer, lot number, dose (e.g. 0.25 mL, 0.5 mL, etc.) and number of dose if part of a series of immunisations against the same disease).",
            "startOffset": 34136,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 32762,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                },
                {
                    "id": "sec0115",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "sec0120",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 32656,
            "title": "Demographics"
        },
        {
            "endOffset": 11132,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0015",
            "sentence": "Twenty-seven articles with potentially relevant material were reviewed in more detail, in order to identify studies using case definitions or, in their absence, providing clinical descriptions of the case material.",
            "startOffset": 10918,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 11347,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0015",
            "sentence": "Data collected from these 27 articles included information on the study type, the vaccine, the diagnostic criteria or case definition put forth, the time interval since time of immunization, and any other symptoms.",
            "startOffset": 11133,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 14685,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "bib0215": {
                    "endOffset": 14684,
                    "startOffset": 14677
                },
                "bib0220": {
                    "endOffset": 14684,
                    "startOffset": 14677
                }
            },
            "secId": "sec0035",
            "sentence": "Preeclampsia can develop up to 6 weeks postpartum and, in fact, 20\u201350% of eclampsia occurs in the postpartum period [12,13].",
            "startOffset": 14561,
            "title": "The timing of development of preeclampsia in the context of vaccine administration"
        },
        {
            "endOffset": 18048,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Proteinuria can be quantified by 24 h urine collection, a spot protein:creatinine ratio, or with urinary dipstick.",
            "startOffset": 17934,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 17039,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "refoffsets": {
                "bib0205": {
                    "endOffset": 17038,
                    "startOffset": 17034
                },
                "bib0235": {
                    "endOffset": 16970,
                    "startOffset": 16966
                }
            },
            "secId": "sec0045",
            "sentence": "The length of time that the blood pressure should remain elevated varies as well, from 15 min [16] to 4 h depending on which organization guidelines are followed [10].",
            "startOffset": 16872,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 11672,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "bib0185": {
                    "endOffset": 11596,
                    "startOffset": 11593
                }
            },
            "secId": "sec0015",
            "sentence": "Only one publication [6] specified the criteria used to diagnose preeclampsia in study participants.",
            "startOffset": 11572,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 23126,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "secId": "sec0065",
            "sentence": "new onset proteinuria (as described above)",
            "startOffset": 23084,
            "title": "Chronic hypertension"
        },
        {
            "endOffset": 18604,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "refoffsets": {
                "bib0245": {
                    "endOffset": 18603,
                    "startOffset": 18599
                }
            },
            "secId": "sec0050",
            "sentence": "The sensitivity and specificity of the protein:creatinine ratio are higher at 93% and 92%, respectively [18].",
            "startOffset": 18495,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 25750,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0080",
            "sentence": "Seizures in pregnancy can be caused by a preexisting seizure disorder, cerebral malaria, metabolic abnormalities, or cerebral anatomic abnormalities such as a space-occupying lesion.",
            "startOffset": 25568,
            "title": "Differential diagnoses"
        },
        {
            "endOffset": 18832,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Given the potential variation in resources available to test for proteinuria, the Brighton Collaboration will permit any of these measures of proteinuria, though 24 h urine collection and protein:creatinine ratio are preferred.",
            "startOffset": 18605,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 19510,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Given the multi-system nature of preeclampsia, these will be presented by system:",
            "startOffset": 19429,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 40302,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Level 2: Criteria as specified in the Hypertensive Disorders of Pregnancy case definition",
            "startOffset": 40213,
            "title": "Data analysis"
        },
        {
            "endOffset": 8020,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "The exact mechanism responsible for hypertensive diseases of pregnancy, in particular preeclampsia, is not known.",
            "startOffset": 7907,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 41942,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "The duration of a possible hypertensive disorder of pregnancy could be analyzed as the interval between the date/time of onset2 of the first symptoms and/or signs consistent with the definition and the end of episode6 and/or final outcome.7",
            "startOffset": 41702,
            "title": "Data analysis"
        },
        {
            "endOffset": 15608,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "However, given that this convention is widely used, the Brighton Collaboration will continue to utilize it for the sake of continuity.",
            "startOffset": 15474,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 10727,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0015",
            "sentence": "To guide the decision-making for the case definition and guidelines, a literature search of publications in English was performed using Medline, Embase and the Cochrane Libraries, including the terms vaccines, vaccination, or immunization (or terms beginning with vaccin-, immuni-, inoculat-), and [hypertension AND pregnancy] or [preeclampsia or eclampsia] (or preeclam-, eclamp-).",
            "startOffset": 10345,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 21691,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "The Brighton Collaboration working groups on stillbirth, intrauterine growth restriction and vaginal bleeding in pregnancy will have publications forthcoming to help guide diagnosis of these related conditions.",
            "startOffset": 21481,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 30489,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0105",
            "sentence": "These guidelines represent a desirable standard for the collection of data on availability following immunization to allow for comparability of data, and are recommended as an addition to data collected for the specific study question and setting.",
            "startOffset": 30242,
            "title": "Data collection"
        },
        {
            "endOffset": 8927,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "Nevertheless, it is important to differentiate hypertensive disorders that predate pregnancy from those that occur during pregnancy, as well as to categorize patients into more or less serious cases.",
            "startOffset": 8728,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 13593,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0030",
            "sentence": "As maximum specificity normally implies a loss of sensitivity, one additional diagnostic levels have been included in the definition, offering a stepwise increase of sensitivity from Level 1 down to Level 2, while retaining an acceptable level of specificity at all levels.",
            "startOffset": 13320,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 16276,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "Regardless of the type of device used to measure blood pressure, accuracy should be checked regularly by comparing the measurement device to a calibrated device, and health care providers should be properly trained in taking blood pressure measurements.",
            "startOffset": 16023,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 29623,
            "parents": [],
            "secId": "sec0100",
            "sentence": "It was the consensus of the Brighton Collaboration Hypertensive Disorders of Pregnancy Working Group to recommend the following guidelines to enable meaningful and standardized collection, analysis, and presentation of information about these conditions.",
            "startOffset": 29369,
            "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
        },
        {
            "endOffset": 20804,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Worsening renal function, as evidenced by serum creatinine level greater than 1.1 mg/dL or a doubling of the serum creatinine (absent other renal disease)",
            "startOffset": 20650,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 16389,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "Blood pressure should be measured with the patient in a seated position, with the arm at the level of the heart.",
            "startOffset": 16277,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 7055,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "There is no universally accepted case definition of gestational hypertension, preeclampsia or eclampsia that occurs following immunisations.",
            "startOffset": 6915,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 22287,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "secId": "sec0060",
            "sentence": "While we recognize HELLP as part of the preeclampsia spectrum of disease, this diagnosis is not the focus of this document, and so will not be further addressed.",
            "startOffset": 22126,
            "title": "HELLP (Hemolysis, Elevated Liver Enzymes, Low Platelets) syndrome"
        },
        {
            "endOffset": 38845,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "The following guidelines represent a desirable standard for analysis of data on the hypertensive disorders of pregnancy to allow for comparability of data, and are recommended as an addition to data analyzed for the specific study question and setting.",
            "startOffset": 38593,
            "title": "Data analysis"
        },
        {
            "endOffset": 15717,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "Accurate blood pressure measurement is fundamental for the diagnosis of a hypertensive disorder of pregnancy.",
            "startOffset": 15608,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 12463,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0025",
            "sentence": "All of these disorders are characterized by elevations in blood pressure.",
            "startOffset": 12390,
            "title": "The terms for hypertension in pregnancy"
        },
        {
            "endOffset": 19102,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "The progression to preeclampsia with severe features represents the clinical recognition of the additional involvement of maternal organ systems.",
            "startOffset": 18957,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 24402,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0075",
            "sentence": "Instead, where feasible, details of this interval should be assessed and reported as described in the data collection guidelines.",
            "startOffset": 24273,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 45787,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "The characteristics of the surveillance system (e.g. population served, mode of report solicitation);",
            "startOffset": 45686,
            "title": "Data presentation"
        },
        {
            "endOffset": 20642,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Liver capsular hemorrhage or liver rupture",
            "startOffset": 20600,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 28970,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Case definitions"
                }
            ],
            "secId": "sec0090",
            "sentence": "Neither case definition nor guidelines are intended to guide or establish criteria for management of ill infants, children, or adults.",
            "startOffset": 28836,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 8727,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "Because of differences among the guidelines issued by international societies, diagnosis can occasionally become confusing as terminology may vary.",
            "startOffset": 8580,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 13319,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0030",
            "sentence": "The case definitions have been formulated such that the Level 1 definition is highly specific for the condition.",
            "startOffset": 13207,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 20599,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Transaminitis (AST and ALT elevated to twice the upper limit of normal)",
            "startOffset": 20528,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 31955,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0105",
            "sentence": "The additional guidelines have been developed as guidance for the collection of additional information to allow for a more comprehensive understanding of development of the hypertensive disorders of pregnancy following immunization.",
            "startOffset": 31723,
            "title": "Data collection"
        },
        {
            "endOffset": 9106,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "The definitive treatment for hypertensive diseases of pregnancy is delivery.",
            "startOffset": 9030,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 15064,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0035",
            "sentence": "Because of the unpredictability in development and progression of the disease, it is important for the purpose of vaccine trials to record the temporal relationship between immunization and development of any preeclampsia-related complication of pregnancy.",
            "startOffset": 14808,
            "title": "The timing of development of preeclampsia in the context of vaccine administration"
        },
        {
            "endOffset": 46309,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "Use of this case definition for the hypertensive disorders of pregnancy, in the abstract or methods section of a publication.12",
            "startOffset": 46182,
            "title": "Data presentation"
        },
        {
            "endOffset": 18264,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "refoffsets": {
                "bib0165": {
                    "endOffset": 18263,
                    "startOffset": 18251
                },
                "bib0205": {
                    "endOffset": 18263,
                    "startOffset": 18251
                },
                "bib0225": {
                    "endOffset": 18263,
                    "startOffset": 18251
                },
                "bib0230": {
                    "endOffset": 18263,
                    "startOffset": 18251
                },
                "bib0235": {
                    "endOffset": 18263,
                    "startOffset": 18251
                }
            },
            "secId": "sec0050",
            "sentence": "Proteinuria of \u2265300 mg in a 24 h urine specimen (the gold standard for measurement of proteinuria), or \u22650.30 on a spot protein:creatinine ratio, or \u22651+ on a dipstick meets the criteria for preeclampsia [2,10,14\u201316].",
            "startOffset": 18049,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 11571,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0015",
            "sentence": "Most publications were of observational studies, though there were also several publications from vaccine adverse event reporting groups.",
            "startOffset": 11434,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 44325,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "Terms to describe hypertensive disorders of pregnancy such as \u201clow-grade\u201d, \u201cmoderate\u201d, \u201chigh\u201d, or \u201csignificant\u201d are highly subjective, prone to wide interpretation, and should be avoided, unless clearly defined.",
            "startOffset": 44114,
            "title": "Data presentation"
        },
        {
            "endOffset": 42544,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Increments specified above should be used.",
            "startOffset": 42502,
            "title": "Data analysis"
        },
        {
            "endOffset": 13838,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0030",
            "sentence": "It needs to be emphasized that the grading of definition levels is entirely about diagnostic certainty, not clinical severity of an event.",
            "startOffset": 13700,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 17458,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "However, with respect to the potential logistical concerns in some settings of keeping a woman for observation for several hours, we propose that a diagnosis of hypertension be made if the systolic blood pressure is \u2265140 mmHg or the diastolic blood pressure is \u226590 mmHg on two measurements at a minimum of one hour apart.",
            "startOffset": 17137,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 19286,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "refoffsets": {
                "bib0250": {
                    "endOffset": 19225,
                    "startOffset": 19221
                }
            },
            "secId": "sec0050",
            "sentence": "Because certain clinical findings associated with severe disease increase the morbidity and mortality of preeclampsia [19], they are included in the Brighton Collaboration definition.",
            "startOffset": 19103,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 24609,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0075",
            "sentence": "Care should be taken to avoid creating spurious associations between vaccine administration and hypertensive disorders, given that vaccines are generally administered during specific times during pregnancy.",
            "startOffset": 24403,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 20035,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Development of a severe headache (which can be diffuse, frontal, temporal or occipital) that generally does not improve with over the counter pain medications (such as acetaminophen/paracetamol)",
            "startOffset": 19841,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 7725,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "bib0160": {
                    "endOffset": 7724,
                    "startOffset": 7721
                }
            },
            "secId": "sec0010",
            "sentence": "Around 10% of all pregnant women will be affected by a hypertensive disorder during pregnancy [1].",
            "startOffset": 7627,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 31086,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0105",
            "sentence": "The Brighton Collaboration has developed guidelines for data collection https://brightoncollaboration.org/public/resources/standards/guidelines.html; and data collection forms https://brightoncollaboration.org/public/resources/data-collection-forms.html.",
            "startOffset": 30832,
            "title": "Data collection"
        },
        {
            "endOffset": 15261,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "refoffsets": {
                "bib0205": {
                    "endOffset": 15260,
                    "startOffset": 15250
                },
                "bib0225": {
                    "endOffset": 15260,
                    "startOffset": 15250
                },
                "bib0230": {
                    "endOffset": 15260,
                    "startOffset": 15250
                }
            },
            "secId": "sec0045",
            "sentence": "Gestational hypertension refers to new onset hypertension after 20 weeks of gestation [10,14,15].",
            "startOffset": 15164,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 24088,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0075",
            "sentence": "We postulate that a definition designed to be a suitable tool for testing associations requires ascertainment of the outcome (e.g. a hypertensive disorder of pregnancy) independent from the exposure (e.g. immunisations).",
            "startOffset": 23868,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 7906,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "bib0160": {
                    "endOffset": 7905,
                    "startOffset": 7900
                },
                "bib0165": {
                    "endOffset": 7905,
                    "startOffset": 7900
                }
            },
            "secId": "sec0010",
            "sentence": "Hypertensive disorders of pregnancy are a significant contributor to maternal and neonatal morbidity and mortality, and are implicated in 10\u201315% of maternal deaths worldwide [1,2].",
            "startOffset": 7726,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 12389,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0025",
            "sentence": "\u201cPregnancy-induced hypertension\u201d is a term referring to hypertensive disorders of pregnancy in general, but lacks the specificity of the other terms, and so the Brighton definitions will refer only to \u201ceclampsia,\u201d \u201cpreeclampsia,\u201d and \u201cgestational hypertension.\u201d",
            "startOffset": 12128,
            "title": "The terms for hypertension in pregnancy"
        },
        {
            "endOffset": 33691,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                },
                {
                    "id": "sec0115",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "sec0125",
            "sentence": "Any medication history (other than treatment for the event described) prior to, during, and after immunization including prescription and non-prescription medication as well as medication or treatment with long half-life or long term effect.",
            "startOffset": 33450,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 20527,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "New onset of nausea, vomiting, epigastric pain",
            "startOffset": 20481,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 43332,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "These guidelines represent a desirable standard for the presentation and publication of data on hypertensive disorders of pregnancy following immunization to allow for comparability of data, and are recommended as an addition to data presented for the specific study question and setting.",
            "startOffset": 43044,
            "title": "Data presentation"
        },
        {
            "endOffset": 43816,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "refoffsets": {
                "bib0300": {
                    "endOffset": 43815,
                    "startOffset": 43808
                },
                "bib0305": {
                    "endOffset": 43815,
                    "startOffset": 43808
                },
                "bib0310": {
                    "endOffset": 43815,
                    "startOffset": 43808
                }
            },
            "secId": "sec0150",
            "sentence": "Additionally, it is recommended to refer to existing general guidelines for the presentation and publication of randomized controlled trials, systematic reviews, and meta-analyses of observational studies in epidemiology (e.g. statements of Consolidated Standards of Reporting Trials (CONSORT), of Improving the quality of reports of meta-analyses of randomized controlled trials (QUORUM), and of Meta-analysis Of Observational Studies in Epidemiology (MOOSE), respectively) [29\u201331].",
            "startOffset": 43333,
            "title": "Data presentation"
        },
        {
            "endOffset": 16022,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "While it is outside the scope of this document to present a comprehensive guide to accurate blood pressure measurement, several important points should be highlighted.",
            "startOffset": 15855,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 22741,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "secId": "sec0065",
            "sentence": "Hypertension that occurs in early gestation is likely to predate pregnancy, hence the establishment of 20 weeks as a boundary for the diagnosis of chronic hypertension.",
            "startOffset": 22573,
            "title": "Chronic hypertension"
        },
        {
            "endOffset": 17934,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Historically, microvascular dysfunction in the kidney has been recognized as proteinuria.",
            "startOffset": 17845,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 30224,
            "parents": [],
            "secId": "sec0100",
            "sentence": "Also, as explained in more detail in the overview paper in this volume, these guidelines have been developed by this working group for guidance only, and are not to be considered a mandatory requirement for data collection, analysis, or presentation.",
            "startOffset": 29974,
            "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
        },
        {
            "endOffset": 32955,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                },
                {
                    "id": "sec0115",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "sec0120",
            "sentence": "Date of birth, age, and sex.",
            "startOffset": 32927,
            "title": "Demographics"
        },
        {
            "endOffset": 41240,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "The interval between immunization and reported hypertensive disorder of pregnancy could be defined as the date/time of immunization to the date/time of onset3 of the first symptoms and/or signs consistent with the definition.",
            "startOffset": 41015,
            "title": "Data analysis"
        },
        {
            "endOffset": 46783,
            "parents": [],
            "secId": "sec0155",
            "sentence": "They do not necessarily represent the official positions of each participant's organization (e.g., government, university, or corporation).",
            "startOffset": 46644,
            "title": "Disclaimer"
        },
        {
            "endOffset": 31722,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0105",
            "sentence": "These data elements include an identifiable reporter and patient, one or more prior immunisations, and a detailed description of the adverse event, in this case, of a hypertensive disorder of pregnancy following immunization.",
            "startOffset": 31497,
            "title": "Data collection"
        },
        {
            "endOffset": 45621,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "The trial profile, indicating participant flow during a study including drop-outs and withdrawals to indicate the size and nature of the respective groups under investigation;",
            "startOffset": 45446,
            "title": "Data presentation"
        },
        {
            "endOffset": 14039,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0030",
            "sentence": "Thus, a clinically very severe event may appropriately be classified as Level 2 rather than Level 1 if it could reasonably be ascribed to an etiology other than the hypertensive diseases of pregnancy.",
            "startOffset": 13839,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 45877,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "Comparison group(s), if used for analysis;",
            "startOffset": 45835,
            "title": "Data presentation"
        },
        {
            "endOffset": 21342,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "refoffsets": {
                "bib0230": {
                    "endOffset": 21118,
                    "startOffset": 21111
                },
                "bib0235": {
                    "endOffset": 21118,
                    "startOffset": 21111
                }
            },
            "secId": "sec0050",
            "sentence": "While complications of pregnancy such as intrauterine growth restriction, placental abruption and stillbirth are utilized as diagnostic criteria for preeclampsia with severe features by some societies [15,16], the Brighton Collaboration has chosen not to include these in our definition since these conditions frequently exist independently of the hypertensive disorders of pregnancy and may represent a separate set of pathologies.",
            "startOffset": 20910,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 45971,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "The instrument of data collection (e.g. standardized questionnaire, diary card, report form);",
            "startOffset": 45878,
            "title": "Data presentation"
        },
        {
            "endOffset": 13700,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0030",
            "sentence": "In this way it is hoped that all possible cases of the hypertensive diseases of pregnancy can be captured.",
            "startOffset": 13594,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 12127,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0025",
            "sentence": "The terms \u201ceclampsia,\u201d \u201cpreeclampsia,\u201d \u201cgestational hypertension\u201d and \u201cpregnancy-induced hypertension\u201d are commonly used in clinical practice.",
            "startOffset": 11985,
            "title": "The terms for hypertension in pregnancy"
        },
        {
            "endOffset": 33149,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                },
                {
                    "id": "sec0115",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "sec0125",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 33043,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 33757,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                },
                {
                    "id": "sec0115",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "sec0125",
            "sentence": "(e.g. immunoglobulins, blood transfusion and immunosuppressants).",
            "startOffset": 33692,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 44825,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "The source of the denominator data should be reported and calculations of estimates be described (e.g. manufacturer data like total doses distributed, reporting through Ministry of Health, coverage/population based data, etc.).",
            "startOffset": 44598,
            "title": "Data presentation"
        },
        {
            "endOffset": 17136,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "The Brighton Collaboration favors a longer time interval of sustained blood pressure elevations.",
            "startOffset": 17040,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 20389,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "refoffsets": {
                "bib0260": {
                    "endOffset": 20389,
                    "startOffset": 20385
                }
            },
            "secId": "sec0050",
            "sentence": "Seizures are often preceded by headaches, visual changes or altered mental status [21]",
            "startOffset": 20303,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 24987,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0075",
            "sentence": "In some settings it may be impossible to obtain a clear timeline of the event, particularly in less developed or rural settings.",
            "startOffset": 24859,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 32616,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                }
            ],
            "secId": "sec0110",
            "sentence": "Relation to the patient (e.g., immunizer [clinician, nurse], family member [indicate relationship], other).",
            "startOffset": 32509,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 41399,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "If few cases are reported, the concrete time course could be analyzed for each; for a large number of cases, data can be analyzed in the following increments:",
            "startOffset": 41241,
            "title": "Data analysis"
        },
        {
            "endOffset": 38976,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Reported events should be classified in one of the following five categories including the three levels of diagnostic certainty.",
            "startOffset": 38848,
            "title": "Data analysis"
        },
        {
            "endOffset": 44111,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "Data on possible hypertensive disorders of pregnancy should be presented in accordance with data collection guidelines 1\u201324 and data analysis guidelines 31\u201336.",
            "startOffset": 43952,
            "title": "Data presentation"
        },
        {
            "endOffset": 40211,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Level 1: Criteria as specified in the Hypertensive Disorders of Pregnancy case definition",
            "startOffset": 40122,
            "title": "Data analysis"
        },
        {
            "endOffset": 25293,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0080",
            "sentence": "Other diagnoses should be considered during the workup of hypertension in pregnancy.",
            "startOffset": 25209,
            "title": "Differential diagnoses"
        },
        {
            "endOffset": 40371,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Event does not meet case definitionAdditional categories for analysis",
            "startOffset": 40302,
            "title": "Data analysis"
        },
        {
            "endOffset": 9244,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "The association of vaccination with the hypertensive diseases of pregnancy has not been well studied and the exact incidence is not known.",
            "startOffset": 9106,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 22572,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "secId": "sec0065",
            "sentence": "Chronic hypertension refers to elevation in the systolic blood pressure to \u2265140 mmHg or the diastolic blood pressure to \u226590 mmHg, sustained over a length of time (as described above) that is diagnosed either prior to pregnancy or prior to 20 weeks gestation.",
            "startOffset": 22314,
            "title": "Chronic hypertension"
        },
        {
            "endOffset": 39264,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Event classification in 5 categories9",
            "startOffset": 39227,
            "title": "Data analysis"
        },
        {
            "endOffset": 16538,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "An appropriate cuff size should be chosen based on the patient's size (generally a length that is 1.5 times the circumference of the patient's arm).",
            "startOffset": 16390,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 39119,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Events that meet the case definition should be classified according to the levels of diagnostic certainty as specified in the case definition.",
            "startOffset": 38977,
            "title": "Data analysis"
        },
        {
            "endOffset": 30831,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0105",
            "sentence": "Investigators developing a data collection tool based on these data collection guidelines also need to refer to the criteria in the case definition, which are not repeated in these guidelines.",
            "startOffset": 30639,
            "title": "Data collection"
        },
        {
            "endOffset": 20462,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "New onset thrombocytopenia, with platelet count <100,000/\u03bcL",
            "startOffset": 20403,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 23009,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "secId": "sec0065",
            "sentence": "The diagnosis of superimposed preeclampsia (preeclampsia superimposed on chronic hypertension) is made based on the following criteria:",
            "startOffset": 22874,
            "title": "Chronic hypertension"
        },
        {
            "endOffset": 28835,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Case definitions"
                }
            ],
            "secId": "sec0090",
            "sentence": "As mentioned in the overview paper, the case definition is accompanied by guidelines which are structured according to the steps of conducting a clinical trial, i.e. data collection, analysis and presentation.",
            "startOffset": 28626,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 34473,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                }
            ],
            "secId": "sec0130",
            "sentence": "The anatomical sites (including left or right side) of all immunisations (e.g. vaccine A in proximal left lateral thigh, vaccine B in left deltoid).",
            "startOffset": 34325,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 42043,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Whatever start and ending are used, they should be used consistently within and across study groups.",
            "startOffset": 41943,
            "title": "Data analysis"
        },
        {
            "endOffset": 42240,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "If more than one measurement of a particular criterion is taken and recorded, the value corresponding to the greatest magnitude of the adverse experience could be used as the basis for analysis.",
            "startOffset": 42046,
            "title": "Data analysis"
        },
        {
            "endOffset": 32413,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                }
            ],
            "secId": "sec0110",
            "sentence": "Name and contact information of person reporting2 and/or diagnosing the hypertensive disorder of pregnancy as specified by country-specific data protection law.",
            "startOffset": 32115,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 46059,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "Whether the day of immunization was considered \u201cday one\u201d or \u201cday zero\u201d in the analysis;",
            "startOffset": 45972,
            "title": "Data presentation"
        },
        {
            "endOffset": 22873,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "refoffsets": {
                "bib0275": {
                    "endOffset": 22872,
                    "startOffset": 22868
                }
            },
            "secId": "sec0065",
            "sentence": "Chronic hypertension progresses to preeclampsia in 10\u201350% of cases, depending on the severity of the preexisting hypertension [24].",
            "startOffset": 22742,
            "title": "Chronic hypertension"
        },
        {
            "endOffset": 23839,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "secId": "sec0070",
            "sentence": "The criteria for a postpartum diagnosis of the hypertensive disorders of pregnancy are the same as the antepartum criteria.",
            "startOffset": 23716,
            "title": "Postpartum preeclampsia"
        },
        {
            "endOffset": 45834,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "The search strategy in surveillance databases;",
            "startOffset": 45788,
            "title": "Data presentation"
        },
        {
            "endOffset": 13206,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0030",
            "sentence": "The number of symptoms and/or signs that will be documented for each case may vary considerably.",
            "startOffset": 13110,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 17751,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "We consider preeclampsia as a systemic condition of endothelial dysfunction in which hypertension is a primary presenting sign.",
            "startOffset": 17624,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 44938,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "The incidence of cases in the study population should be presented and clearly identified as such in the text.",
            "startOffset": 44828,
            "title": "Data presentation"
        },
        {
            "endOffset": 9029,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "Furthermore, the specific diagnosis has important treatment implications, such as timing of delivery.",
            "startOffset": 8928,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 29021,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Case definitions"
                }
            ],
            "secId": "sec0090",
            "sentence": "Both were developed to improve data comparability.",
            "startOffset": 28971,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 20123,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "refoffsets": {
                "bib0255": {
                    "endOffset": 20123,
                    "startOffset": 20119
                }
            },
            "secId": "sec0050",
            "sentence": "Development of visual changes (including photopsia, scotomata, cortical blindness) [20]",
            "startOffset": 20036,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 10788,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0015",
            "sentence": "The search resulted in the identification of 516 references.",
            "startOffset": 10728,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 8265,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "bib0170": {
                    "endOffset": 8264,
                    "startOffset": 8259
                },
                "bib0175": {
                    "endOffset": 8264,
                    "startOffset": 8259
                }
            },
            "secId": "sec0010",
            "sentence": "One leading hypothesis is that abnormalities in the development of the uteroplacental unit lead to increased hypoxemia and oxidative stress, which in turn lead to endothelial dysfunction and abnormalities in vascular tone and coagulation [3,4].",
            "startOffset": 8021,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 41477,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Subjects with a hypertensive disorder of pregnancy by interval to presentation",
            "startOffset": 41399,
            "title": "Data analysis"
        },
        {
            "endOffset": 42660,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "When only a small number of cases is presented, the respective values or time course can be presented individually.",
            "startOffset": 42545,
            "title": "Data analysis"
        },
        {
            "endOffset": 45685,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "The type of surveillance (e.g. passive or active surveillance);",
            "startOffset": 45622,
            "title": "Data presentation"
        },
        {
            "endOffset": 24858,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "bib0160": {
                    "endOffset": 24779,
                    "startOffset": 24776
                }
            },
            "secId": "sec0075",
            "sentence": "Further, hypertensive disorders of pregnancy are common, affecting up to 10% of pregnant women [1], and can occur outside the controlled setting of a clinical trial or hospital.",
            "startOffset": 24681,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 7378,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "As immunization is considered an essential element of care in pregnancy, the potential complications of this procedure should be understood.",
            "startOffset": 7238,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 43949,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "All reported events of hypertensive disorders of pregnancy should be presented according to the categories listed in guideline 31.",
            "startOffset": 43819,
            "title": "Data presentation"
        },
        {
            "endOffset": 45305,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "Any publication of data on the hypertensive disorders of pregnancy should include a detailed description of the methods used for data collection and analysis as possible.",
            "startOffset": 45135,
            "title": "Data presentation"
        },
        {
            "endOffset": 18494,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "refoffsets": {
                "bib0245": {
                    "endOffset": 18493,
                    "startOffset": 18489
                }
            },
            "secId": "sec0050",
            "sentence": "Automated urinalysis improves the sensitivity of this test to 74% [18].",
            "startOffset": 18423,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 34627,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                }
            ],
            "secId": "sec0130",
            "sentence": "Route and method of administration (e.g. intramuscular, intradermal, subcutaneous, and needle-free (including type and size), other injection devices).",
            "startOffset": 34476,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 19828,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Severely elevated blood pressures, with systolic blood pressure \u2265160 mmHg and/or diastolic blood pressure \u2265110 mmHg, which is confirmed after only minutes (to facilitate timely antihypertensive treatment)",
            "startOffset": 19624,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 21480,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "We recommend that these complications should certainly be reported as pregnancy outcomes in the context of vaccine and other drug trials.",
            "startOffset": 21343,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 45066,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "If the distribution of data is skewed, median and range are usually the more appropriate statistical descriptors than a mean.",
            "startOffset": 44941,
            "title": "Data presentation"
        },
        {
            "endOffset": 12847,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0025",
            "sentence": "The diagnosis of gestational hypertension is provisional, in that every woman with new blood pressure elevation in pregnancy should be further evaluated for the development of preeclampsia.",
            "startOffset": 12658,
            "title": "The terms for hypertension in pregnancy"
        },
        {
            "endOffset": 10917,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0015",
            "sentence": "All abstracts were screened for possible reports of preeclampsia, eclampsia or hypertension in pregnancy following immunization.",
            "startOffset": 10789,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 32925,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                },
                {
                    "id": "sec0115",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "sec0120",
            "sentence": "Case/study participant identifiers (e.g. first name initial followed by last name initial) or code (or in accordance with country-specific data protection laws).",
            "startOffset": 32764,
            "title": "Demographics"
        },
        {
            "endOffset": 24272,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0075",
            "sentence": "Therefore, to avoid selection bias, a restrictive time interval from immunization to onset of a hypertensive disorder of pregnancy should not be an integral part of such a definition.",
            "startOffset": 24089,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 31496,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "refoffsets": {
                "bib0290": {
                    "endOffset": 31372,
                    "startOffset": 31368
                },
                "bib0295": {
                    "endOffset": 31495,
                    "startOffset": 31491
                }
            },
            "secId": "sec0105",
            "sentence": "Guidelines below have been developed to address data elements for the collection of adverse event information as specified in general drug safety guidelines by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use [27], and the form for reporting of drug adverse events by the Council for International Organizations of Medical Sciences [28].",
            "startOffset": 31086,
            "title": "Data collection"
        },
        {
            "endOffset": 29704,
            "parents": [],
            "secId": "sec0100",
            "sentence": "However, implementation of all guidelines might not be possible in all settings.",
            "startOffset": 29624,
            "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
        },
        {
            "endOffset": 23083,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "secId": "sec0065",
            "sentence": "preexisting hypertension (described above) PLUS any one of the following:",
            "startOffset": 23010,
            "title": "Chronic hypertension"
        },
        {
            "endOffset": 16871,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "Blood pressure is considered elevated if the systolic blood pressure is \u2265140 mmHg or the diastolic blood pressure is \u226590 mmHg, sustained over time.",
            "startOffset": 16724,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 14456,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "bib0205": {
                    "endOffset": 14372,
                    "startOffset": 14368
                }
            },
            "secId": "sec0035",
            "sentence": "Preeclampsia and gestational hypertension are conventionally defined as developing after 20 weeks gestation [10], but there can be great variability in exact timing of presentation of the disease.",
            "startOffset": 14260,
            "title": "The timing of development of preeclampsia in the context of vaccine administration"
        },
        {
            "endOffset": 22125,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "secId": "sec0060",
            "sentence": "It is important to note that hypertension may be absent in up to 15% of cases of HELLP syndrome.",
            "startOffset": 22029,
            "title": "HELLP (Hemolysis, Elevated Liver Enzymes, Low Platelets) syndrome"
        },
        {
            "endOffset": 13000,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0025",
            "sentence": "It is possible to move from a diagnosis of gestational hypertension to preeclampsia or eclampsia, but not from preeclampsia to gestational hypertension.",
            "startOffset": 12848,
            "title": "The terms for hypertension in pregnancy"
        },
        {
            "endOffset": 18956,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Preeclampsia can be further classified as having \u201csevere features\u201d with development of laboratory abnormalities or symptoms.",
            "startOffset": 18832,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 40120,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Event meets case definition",
            "startOffset": 40093,
            "title": "Data analysis"
        },
        {
            "endOffset": 20841,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Oliguria (urine output <500 mL/24 h)",
            "startOffset": 20805,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 18422,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "refoffsets": {
                "bib0240": {
                    "endOffset": 18421,
                    "startOffset": 18417
                }
            },
            "secId": "sec0050",
            "sentence": "Routine visual dipstick urinalysis has been shown to have false positive rates at \u201c1+\u201d of 67\u201383%, and false negative rates at \u201cnil\u201d or \u201ctrace\u201d of 8\u201318% [17].",
            "startOffset": 18265,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 23715,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "refoffsets": {
                "bib0285": {
                    "endOffset": 23714,
                    "startOffset": 23710
                }
            },
            "secId": "sec0070",
            "sentence": "The exact incidence of new-onset postpartum preeclampsia or hypertension is difficult to measure since most women do not return to their care provider until 6 weeks after the delivery, but estimates range from 0.3% to 27%[26].",
            "startOffset": 23489,
            "title": "Postpartum preeclampsia"
        },
        {
            "endOffset": 40705,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Reported hypertensive disorder of pregnancy with insufficient evidence to meet the case definition10,11",
            "startOffset": 40373,
            "title": "Data analysis"
        },
        {
            "endOffset": 30638,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0105",
            "sentence": "The guidelines are not intended to guide the primary reporting of the hypertensive disorders of pregnancy to a surveillance system or study monitor.",
            "startOffset": 30490,
            "title": "Data collection"
        },
        {
            "endOffset": 25567,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0080",
            "sentence": "The differential is broad, including but not limited to conditions such as preexisting renal disease, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome, acute fatty liver of pregnancy, primary liver disease, cardiomyopathy, pheochromocytoma, and thyrotoxicosis.",
            "startOffset": 25294,
            "title": "Differential diagnoses"
        },
        {
            "endOffset": 11821,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "bib0165": {
                    "endOffset": 11820,
                    "startOffset": 11813
                },
                "bib0190": {
                    "endOffset": 11820,
                    "startOffset": 11813
                },
                "bib0195": {
                    "endOffset": 11820,
                    "startOffset": 11813
                },
                "bib0200": {
                    "endOffset": 11820,
                    "startOffset": 11813
                }
            },
            "secId": "sec0015",
            "sentence": "Four of the publications reported using ICD-9 diagnostic codes to collect cases of preeclampsia/eclampsia or pregnancy related hypertension [2,7\u20139].",
            "startOffset": 11673,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 43024,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Data on hypertensive disorders of pregnancy obtained from subjects receiving a vaccine should be compared with those obtained from an appropriately selected and documented control group(s) to assess background rates of hypersensitivity in non-exposed populations, and should be analyzed by study arm and dose where possible, e.g. in prospective clinical trials.",
            "startOffset": 42663,
            "title": "Data analysis"
        },
        {
            "endOffset": 14560,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "refoffsets": {
                "bib0210": {
                    "endOffset": 14559,
                    "startOffset": 14555
                }
            },
            "secId": "sec0035",
            "sentence": "In one study, approximately 10% of the preeclampsia diagnoses were made before 34 weeks gestation [11].",
            "startOffset": 14457,
            "title": "The timing of development of preeclampsia in the context of vaccine administration"
        },
        {
            "endOffset": 19613,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "NOTE that preeclampsia with severe features can be diagnosed in the presence or absence of proteinuria.",
            "startOffset": 19510,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 12657,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0025",
            "sentence": "Preeclampsia and eclampsia have additional diagnostic criteria based on laboratory findings by clinical physical exam or patient reported symptoms reflecting the systemic nature of the disease.",
            "startOffset": 12464,
            "title": "The terms for hypertension in pregnancy"
        },
        {
            "endOffset": 33003,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                },
                {
                    "id": "sec0115",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "sec0120",
            "sentence": "For infants: Gestational age and birth weight.",
            "startOffset": 32957,
            "title": "Demographics"
        },
        {
            "endOffset": 11434,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0015",
            "sentence": "References that lacked hypertensive diseases of pregnancy as an outcome were excluded.",
            "startOffset": 11348,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 24681,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0075",
            "sentence": "Case\u2013control studies are needed to further evaluate the potential link.",
            "startOffset": 24610,
            "title": "Timing post immunization"
        },
        {
            "endOffset": 32507,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                }
            ],
            "secId": "sec0110",
            "sentence": "Name and contact information of the investigator responsible for the subject, as applicable.",
            "startOffset": 32415,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 16724,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "The disappearance of sounds, or the fifth phase, is the best measurement of diastolic blood pressure.",
            "startOffset": 16623,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 34654,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                }
            ],
            "secId": "sec0130",
            "sentence": "Needle length and gauge.",
            "startOffset": 34630,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 46181,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "Whether the date of onset3 and/or the date of first observation4 and/or the date of diagnosis5 was used for analysis; and",
            "startOffset": 46060,
            "title": "Data presentation"
        },
        {
            "endOffset": 14807,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0035",
            "sentence": "The progression from normal blood pressure to hypertension to preeclampsia can proceed rapidly, gradually, or not at all.",
            "startOffset": 14686,
            "title": "The timing of development of preeclampsia in the context of vaccine administration"
        },
        {
            "endOffset": 14173,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                }
            ],
            "secId": "sec0030",
            "sentence": "Detailed information about the severity of the event should additionally be recorded, as specified by the data collection guidelines.",
            "startOffset": 14040,
            "title": "Formulating a case definition that reflects diagnostic certainty: weighing specificity versus sensitivity"
        },
        {
            "endOffset": 23271,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "secId": "sec0065",
            "sentence": "development of any of the laboratory abnormalities or clinical findings consistent with severe preeclampsia",
            "startOffset": 23164,
            "title": "Chronic hypertension"
        },
        {
            "endOffset": 23488,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "refoffsets": {
                "bib0280": {
                    "endOffset": 23487,
                    "startOffset": 23483
                }
            },
            "secId": "sec0070",
            "sentence": "While some of the physiologic changes of pregnancy take longer to return to a pre-pregnancy state, the postpartum period, or puerperium, encompasses the six weeks following delivery [25].",
            "startOffset": 23301,
            "title": "Postpartum preeclampsia"
        },
        {
            "endOffset": 29242,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Case definitions"
                }
            ],
            "secId": "sec0095",
            "sentence": "Similar to all Brighton Collaboration case definitions and guidelines, review of the definition with its guidelines is planned on a regular basis (i.e. every three to five years) or more often if needed.",
            "startOffset": 29039,
            "title": "Periodic review"
        },
        {
            "endOffset": 32096,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                }
            ],
            "secId": "sec0110",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 31990,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 41012,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Not a case of a hypertensive disorder of pregnancy",
            "startOffset": 40962,
            "title": "Data analysis"
        },
        {
            "endOffset": 29973,
            "parents": [],
            "secId": "sec0100",
            "sentence": "The availability of information may vary depending upon resources, geographical region, and whether the source of information is a prospective clinical trial, a post-marketing surveillance or epidemiological study, or an individual report of hypertension in pregnancy.",
            "startOffset": 29705,
            "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
        },
        {
            "endOffset": 45132,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "However, the mean and standard deviation should also be provided.",
            "startOffset": 45067,
            "title": "Data presentation"
        },
        {
            "endOffset": 33959,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                },
                {
                    "id": "sec0115",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "sec0125",
            "sentence": "Immunization history (i.e. previous immunisations and any adverse event following immunization (AEFI)), in particular occurrence of a hypertensive disorder in pregnancy after a previous immunization.",
            "startOffset": 33760,
            "title": "Clinical and immunization history"
        },
        {
            "endOffset": 34097,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                },
                {
                    "id": "sec0105",
                    "title": "Data collection"
                }
            ],
            "secId": "sec0130",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 33991,
            "title": "Details of the immunization"
        },
        {
            "endOffset": 7559,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "Additionally, vaccine studies may be conducted in a variety of settings, including those with fewer resources to perform the same diagnostic testing as in higher resource settings.",
            "startOffset": 7379,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 20302,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0050",
            "sentence": "Eclampsia, or new-onset grand mal seizures in a patient with preeclampsia, without other provoking factors (such as evidence of cerebral malaria or preexisting seizure disorder).",
            "startOffset": 20124,
            "title": "Preeclampsia"
        },
        {
            "endOffset": 44597,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "Although immunization safety surveillance systems denominator data are usually not readily available, attempts should be made to identify approximate denominators.",
            "startOffset": 44434,
            "title": "Data presentation"
        },
        {
            "endOffset": 16622,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0040",
                    "title": "Rationale for individual criteria related to the case definition"
                }
            ],
            "secId": "sec0045",
            "sentence": "The systolic blood pressure is the pressure at which the first sounds can be heard.",
            "startOffset": 16539,
            "title": "Gestational hypertension"
        },
        {
            "endOffset": 42501,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "The distribution of data (as numerator and denominator data) could be analyzed in predefined increments (e.g. measured values, times), where applicable.",
            "startOffset": 42349,
            "title": "Data analysis"
        },
        {
            "endOffset": 39227,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0145",
            "sentence": "Events that do not meet the case definition should be classified in the additional categories for analysis.",
            "startOffset": 39120,
            "title": "Data analysis"
        },
        {
            "endOffset": 45333,
            "parents": [
                {
                    "id": "sec0100",
                    "title": "Guidelines for data collection, analysis and presentation of the hypertensive disorders of pregnancy, as presented in document"
                }
            ],
            "secId": "sec0150",
            "sentence": "It is essential to specify:",
            "startOffset": 45306,
            "title": "Data presentation"
        },
        {
            "endOffset": 8579,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "secId": "sec0010",
            "sentence": "Hypertensive disease in pregnancy encompasses a spectrum of conditions, including gestational hypertension, preeclampsia (which can be further qualified as having severe features), eclampsia, chronic hypertension with superimposed preeclampsia and HELLP (Hemolysis, Elevated Liver Enzymes, Low Platelets) syndrome.",
            "startOffset": 8265,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 23163,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                },
                {
                    "id": "sec0020",
                    "title": "Rationale for selected decisions about the case definition of preeclampsia as an adverse event following immunization"
                },
                {
                    "id": "sec0055",
                    "title": "Related conditions"
                }
            ],
            "secId": "sec0065",
            "sentence": "worsening of preexisting proteinuria",
            "startOffset": 23127,
            "title": "Chronic hypertension"
        },
        {
            "endOffset": 10075,
            "parents": [
                {
                    "id": "sec0005",
                    "title": "Preamble"
                }
            ],
            "refoffsets": {
                "bib0180": {
                    "endOffset": 9808,
                    "startOffset": 9805
                }
            },
            "secId": "sec0015",
            "sentence": "Following the process described in the overview paper [5] as well as on the Brighton Collaboration Website, http://www.brightoncollaboration.org/internet/en/index/process.html, the Brighton Collaboration Preeclampsia Working Group was formed in 2015 and included members with clinical, academic and public health background.",
            "startOffset": 9751,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for the hypertensive disorders of pregnancy as adverse events following immunization"
        },
        {
            "endOffset": 46942,
            "parents": [],
            "secId": "sec0155",
            "sentence": "Specifically, the findings and conclusions in this paper are those of the authors and do not necessarily represent the views of their respective institutions.",
            "startOffset": 46784,
            "title": "Disclaimer"
        }
    ],
    "docId": "S0264410X16300214",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Caroline E.",
                "initial": "C.E.",
                "last": "Rouse"
            },
            {
                "email": null,
                "first": "Linda O.",
                "initial": "L.O.",
                "last": "Eckert"
            },
            {
                "email": null,
                "first": "Blair J.",
                "initial": "B.J.",
                "last": "Wylie"
            },
            {
                "email": null,
                "first": "Deirdre J.",
                "initial": "D.J.",
                "last": "Lyell"
            },
            {
                "email": null,
                "first": "Arundhathi",
                "initial": "A.",
                "last": "Jeyabalan"
            },
            {
                "email": null,
                "first": "Sonali",
                "initial": "S.",
                "last": "Kochhar"
            },
            {
                "email": "contact@brightoncollaboration.org",
                "first": "Thomas F.",
                "initial": "T.F.",
                "last": "McElrath"
            },
            {
                "email": null,
                "first": null,
                "initial": null,
                "last": null
            }
        ],
        "doi": "10.1016/j.vaccine.2016.03.038",
        "firstpage": "6069",
        "issn": "0264410X",
        "keywords": [
            "Adverse event",
            "Case definition",
            "Guidelines",
            "Hypertension in pregnancy",
            "Immunization",
            "Preeclampsia"
        ],
        "lastpage": "6076",
        "openaccess": "Full",
        "pub_year": 2016,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Hypertensive disorders of pregnancy: Case definitions & guidelines for data collection, analysis, and presentation of immunization safety data"
    }
}